Refined finite element modelling of tapered steel portal frames
ce/papers · 2026-09 · 9 (2-3) · 2061-2066
DOI: 10.1002/cepa.70576 ↗Kurz gefasst
Fachartikel in der Zeitschrift ce/papers, online erschienen am 14.09.2026. Verfasst von Baptiste Bernard und 2 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Many studies have been dedicated to the stability of slender/thin‐walled tapered I‐beam, columns from numerical, experimental and analytical points of view but very few on full‐scale steel portal frames close to current practice. The stability of members of portal frames can be estimated by the General method of Eurocode 3 part 1‐1. In addition, the new Eurocode 3 part 1‐14 introduces requirements to model numerically these members. The objective of the present paper is to perform finite element analysis using shell elements on full‐scale portal frame applying the new requirements of Eurocode 3 part 1‐14 and confront these results to the standard procedures of Eurocode 3 part 1‐1. The finite element model is firstly confronted to experimental tests performed on portal frames. Next, portal frames in line with current practice are designed according to Eurocode 3 part 1‐1, and modelled using shell elements in ANSYS applying the requirements of Eurocode 3 part 1‐14. The resistance obtained with the two approaches are compared and the differences are discussed.
Zitieren
APA
Bernard, B., Couchaux, M., & Charrier, L. (2026). Refined finite element modelling of tapered steel portal frames. ce/papers, 9(2-3), 2061-2066. https://doi.org/10.1002/cepa.70576
Vancouver
Bernard B, Couchaux M, Charrier L. Refined finite element modelling of tapered steel portal frames. ce/papers. 2026;9(2-3):2061-2066. doi:10.1002/cepa.70576
BibTeX
@article{Bernard2026,
author = {Bernard, Baptiste and Couchaux, Maël and Charrier, Laurent},
title = {Refined finite element modelling of tapered steel portal frames},
journal = {ce/papers},
year = {2026},
volume = {9},
number = {2-3},
pages = {2061--2066},
doi = {10.1002/cepa.70576}
}
EUVIMED